Updated February 12 at 7:12pm
Life Sciences
78 results total, viewing 1 - 10
Six years ago, none of the five Brown University researchers with a major new grant from the ALS Finding a Cure Foundation had even worked on amyotrophic lateral sclerosis. That’s exactly why the team has a unique approach for making much-needed progress against the untreatable neurodegenerative disease. more
Dr. Anne S. De Groot is the founder, immune engineer, chief scientific officer and CEO of Providence-based vaccine company EpiVax, which champions the "vaccines-on-demand" movement. She talks with Providence Business News about her experience as a panelist at a health care conference, "The Immunology Revolution: Here Now or Hurry Up and Wait?" more
Scientists at the URI Graduate School of Oceanography will present their research at the 2016 Ocean Sciences Meeting in New Orleans Feb. 24 to 26. more
Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling stock market to beef up cost-controlling technologies that may be critical to maintaining growth. more
One in 68 children in the United States has been diagnosed with autism spectrum disorder, according to the Centers for Disease Control and Prevention. Of those, about 25 percent are never able to talk. more
Dogs have been used for decades to sniff out explosives, but now a University of Rhode Island scientist and his team have come up with another way to detect bombs: sensors. more
Xinyuan “Shawn” Chen, assistant professor of biomedical and pharmaceutical sciences at the University of Rhode Island’s College of Pharmacy, is developing a nicotine vaccine to block the drug’s entry into a smoker’s brain. more
A national consultant has advised the I-195 Redevelopment District Commission to create a business innovation district in Providence that is larger than the existing footprint of undeveloped land, and to create an advisory council that would include the perspectives of anchor industries and universities. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
Andy Trench was building drones to fly cameras for filming when he was posed with a challenge: Assess the condition of a 60-foot-tall cupola atop a 100-year-old Pawtucket church. The challenge resulted in the production of a lightweight … more
1 | 2 | 3 | 4 | 5 | 6 | 7 8 | Next »